Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment-Reference-Cited by-同舟云学术

Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment

Published:2021-01-01 Issue:1 Volume:24 Page:1018-1024
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Goel Nicholas J.¹,Bird Cylaina E.²,Hicks William H.²^ORCID,Abdullah Kalil G.²

Affiliation:

1. Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

2. Department of Neurological Surgery, The University of Texas Southwestern Medical Center, Dallas, TX, USA

Funder

Eugene P. Frenkel, M.D. Award Program

The University of Texas Southwestern Medical Center – Dallas holds a Physician-Scientist Institutional Award from the Burroughs Wellcome Fund

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1964775

Reference30 articles.

1. Projections of the Cost of Cancer Care in the United States: 2010-2020

2. When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology

3. Cost–effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme

4. Consumer price index estimated from the United States Bureau of Labor Statistics. 2017. Available from: http://www.bls.gov/data/inflation_calculator.htm

5. OECD. Purchasing power parities (PPP) OECD.ORG: Organization for Economic Cooperation and Development. 2017. Available from: https://data.oecd.org/conversion/PURCHASING-POWER-PARITIES-PPP.HTM

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme;Cells;2024-01-10

2. Regulation of cancer stem cells and immunotherapy of glioblastoma (Review);Biomedical Reports;2023-12-19

3. A retrospective analysis of practical benefits and caveats of the new WHO 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”;Neuropathology;2023-11-29

4. Characterization of tumor microenvironment in glioblastoma multiforme identifies ITGB2 as a key immune and stromal related regulator in glial cell types;Computers in Biology and Medicine;2023-10

5. Uncertainty quantification and attention-aware fusion guided multi-modal MR brain tumor segmentation;Computers in Biology and Medicine;2023-09